JPMORGAN CHASE & CO - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 90 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$129,578
-14.2%
34,280
+52.1%
0.00%
Q2 2023$150,978
+694.6%
22,534
+671.2%
0.00%
Q1 2023$19,000
+86263.6%
2,922
+13.6%
0.00%
Q4 2022$22
-99.8%
2,572
+21.8%
0.00%
Q3 2022$11,000
+83.3%
2,111
+41.0%
0.00%
Q2 2022$6,000
-87.8%
1,497
-89.1%
0.00%
Q1 2022$49,000
-95.7%
13,758
-92.0%
0.00%
Q4 2021$1,144,000
+131.1%
171,824
+246.1%
0.00%
Q3 2021$495,000
+76.2%
49,650
+445.9%
0.00%
Q2 2021$281,000
-77.3%
9,095
-67.9%
0.00%
Q1 2021$1,237,00028,3500.00%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
EcoR1 Capital, LLC 2,618,036$80,871,0003.02%
Orbimed Advisors 8,740,887$270,006,0002.73%
Boxer Capital, LLC 1,675,377$51,752,0001.83%
Endurant Capital Management LP 139,124$4,298,0001.18%
Nantahala Capital Management 1,266,266$39,115,0001.11%
COMMODORE CAPITAL LP 97,143$3,001,0001.05%
Ally Bridge Group (NY) LLC 128,572$3,972,0000.99%
RA Capital Management 1,742,186$53,816,0000.86%
HighVista Strategies LLC 25,906$800,0000.57%
SPHERA FUNDS MANAGEMENT LTD. 173,891$5,371,0000.36%
View complete list of SILVERBACK THERAPEUTICS INC shareholders